GLP-1 Medication Users Face Financial Trade-offs Between Health Costs and Retirement Savings
A new survey by the Nationwide Retirement Institute reveals that half of current GLP-1 medication users worry they may have to choose between paying for their treatment and saving enough for retirement. Nearly a quarter prioritize maintaining access to their medication over increasing savings, with many already altering financial behaviors such as taking on debt or withdrawing from accounts. Despite these challenges, most users remain optimistic about long-term health benefits of GLP-1s, which are reducing the perceived urgency to boost retirement savings and decreasing concerns about future insurance needs. However, this optimism may mask a planning gap: while people expect longer lives due to improved health, many lack financial readiness for extended retirements. The average out-of-pocket cost is $203 per month for those not fully insured, with nearly 60% worried they will struggle to afford the medication in retirement. The findings highlight an evolving conversation around how medical advancements are reshaping both expectations and challenges of long-term financial planning.
Topics: financial impact GLP-1 medications health optimism retirement planning